(Press-News.org) The burden of liver disease could be dramatically reduced by scaling up the combination of interventions for hepatitis C infection among people who inject drugs according to University of Bristol researchers. The findings, published today [24 July], form part of new global recommendations on treating the virus.
Around 150 million people globally are chronically infected with the hepatitis C virus (HCV)1 – a major cause of liver disease that can lead to serious complications such as liver failure or cancer, which are associated with considerable costs to the health care system. In developed countries the majority of transmissions and cases are among people who inject drugs2 – in the UK, this equates to around 90 per cent of hepatitis C infections.3
The study, published today in the journal Clinical Infectious Diseases by Dr Natasha Martin and colleagues at University of Bristol, the London School of Hygiene and Tropical Medicine and Health Protection Scotland, suggests that combining HCV antiviral treatment with opiate substitution therapy (OST) such as methadone and buprenorphine, and high-coverage needle and syringe programmes (HCNSP) is critical for achieving substantial reductions by up to 50 per cent over ten years.
Matthew Hickman, Professor in Public Health and Epidemiology at Bristol's School of Social and Community Medicine and co-author of the research, said: "High-coverage needle and syringe programmes (NSP) and opiate substitution therapy (OST) are the key primary interventions to treat hepatitis C among people who inject drugs; but HCV treatment is required if we want to achieve greater than 45 per cent reduction in HCV prevalence over a ten year period.
"Our model projections show that scaling up OST and high coverage NSP can reduce the number of HCV treatments required to achieve reductions in HCV – and emphasises the importance of a combination of interventions. Further research is needed to examine the cost effectiveness and affordability of scaling up HCV treatment."
The research supports the first set of global recommendations, published by the International Network on Hepatitis Care in Substance Users (INHSU), ever released for treating hepatitis C in people who inject drugs which has shown that treatment can be very successful when barriers are addressed within a supportive environment.
Philip Bruggmann, President of the INHSU, who have published the recommendations on treating the disease in substance users, said: "Reducing the significant burden of liver disease related to hepatitis C internationally will require improved HCV care in the population most affected: those people who currently inject or formerly injected drugs. By providing appropriate care to this group, we can reduce the burden of hepatitis C-related liver disease in this vulnerable population and slow the spread of this global epidemic. These new recommendations serve as a first step in eliminating hepatitis C."
###
Paper
The study 'Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment,Needle and Syringe Programs, and Opiate
Substitution Therapy' is published today [24 July] in the journal Clinical Infectious Diseases.
Global recommendations
The global recommendations are published online today [24 July] in the journal Clinical Infectious Diseases in a supplement entitled 'Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward'.
Further information:
1. World Health Organisation: http://www.who.int/mediacentre/factsheets/fs164/en/
2. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-67
3. An evidence synthesis approach to estimating hepatitis C prevalence in England and Wales. Stat Methods Med Res 2009; 18:361-79.
4. About hepatitis C
Hepatitis C is a blood-borne virus that predominantly infects the cells of the liver. This can result in inflammation and significant damage to the liver. It can also affect the liver's ability to perform its essential functions. Although it has always been regarded as a liver disease - 'hepatitis' means 'inflammation of the liver' - recent research has shown that the hepatitis C virus (HCV) affects a number of other areas of the body. These can include the digestive system, the lymphatic system, the immune system and the brain.
Source: The Hepatitis Trust - http://www.hepctrust.org.uk/Hepatitis_C_Info/About+Hepatitis+C/About+Hepatitis+C
Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C
2013-07-25
ELSE PRESS RELEASES FROM THIS DATE:
Shedding new light on the brightest objects in the universe
2013-07-25
A Dartmouth-led team of astrophysicists has discovered the extent to which quasars and their black holes can influence their galaxies.
The team is scheduled to publish a paper in The Astrophysical Journal, detailing discoveries based upon observations of 10 quasars. The paper is now publicly available through the Cornell University Library.
The researchers documented the immense power of quasar radiation, reaching out for many thousands of light years to the limits of the quasar's galaxy.
"For the first time, we are able to see the actual extent to which these quasars ...
Western-led 'international beam team' solves Martian meteorite age puzzle
2013-07-25
By directing energy beams at tiny crystals found in a Martian meteorite, a Western University-led team of geologists has proved that the most common group of meteorites from Mars is almost 4 billion years younger than many scientists had believed – resolving a long-standing puzzle in Martian science and painting a much clearer picture of the Red Planet's evolution that can now be compared to that of habitable Earth.
For more information, video and downloadable images, please visit http://communications.uwo.ca/media/agepuzzle/.
In a paper published today in the journal ...
Smithsonian finds color patterns in fish larvae may reveal relationships among species
2013-07-25
Similarities in how different organisms look can indicate a close evolutionary relationship. Conversely, great differences in appearance can suggest a very distant relationship, as in many adult marine fish species. For the first time, however, a Smithsonian scientist has found that color patterns of different fish species in the larval stage can be very similar, revealing a closer evolutionary relationship than their adult forms would suggest. The research is published in the July issue of the Zoological Journal of the Linnean Society.
Many marine fish species spend ...
Monoclonal antibody effective against norovirus
2013-07-25
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
"We initiated this work because there is presently no virus-specific treatment or vaccine to control the norovirus illness," says Kim Y. Green, a researcher on the study. "Our working hypothesis was that a highly specific norovirus antibody ...
A promising target to treat asthma
2013-07-25
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers say.
Asthma affects billions of people worldwide. In the United States, 8.5 percent of the population has asthma, which causes 3,000 deaths and more than $56 billion annually in medical and ...
More central line infections seen in children with cancer once they leave the hospital
2013-07-25
Pediatric cancer patients whose central lines are used to treat them at home develop three times as many dangerous bloodstream infections from their devices than their hospitalized counterparts, according to the results of a new Johns Hopkins Children's Center study.
Findings of the research, reported online July 23 in the journal Pediatric Blood & Cancer, provide valuable insight into the safety of central line uses outside the hospital and underscore the need to carefully evaluate the benefits and risk of sending a child home with one, the investigators say.
Furthermore, ...
Are North Atlantic right whales mating in the Gulf of Maine?
2013-07-25
Using data obtained during six years of regular aerial surveys and genetics data collected by a consortium of research groups, scientists have strengthened evidence pointing to the central Gulf of Maine as a mating ground for North Atlantic right whales, according to a study recently published online in the journal Endangered Species Research.
The North Atlantic right whale (Eubalaena glacialis) is one of the most endangered marine mammal species in the world and has been intensively studied for decades. Much has been learned about its habitat, behavior, and population ...
Newly discovered marine viruses offer glimpse into untapped biodiversity
2013-07-25
Researchers of the University of Arizona's Tucson Marine Phage Lab have discovered a dozen new types of unknown viruses that infect different strains of marine bacteria.
Bacteriophages – viruses that prey on bacteria – are less familiar to most people than their flu- or cold-causing cousins, but they control processes of global importance. For example, they determine how much oxygen goes from the oceans into the atmosphere in exchange for carbon dioxide, they influence climate patterns across the Earth and they alter the assemblages of microorganisms competing in the ...
New genetic cause of pulmonary hypertension identified
2013-07-25
NEW YORK, NY (July 25, 2013) — Columbia University Medical Center (CUMC) scientists have identified new genetic mutations that can cause pulmonary arterial hypertension (PAH), a rare fatal disease characterized by high blood pressure in the lungs. The mutations, found in the gene KCNK3, appear to affect potassium channels in the pulmonary artery, a mechanism not previously linked to the condition. Cell culture studies showed that the mutations' effects could be reversed with a drug compound known as a phospholipase inhibitor. The study was published today in the online ...
Boreal forests in Alaska becoming more flammable
2013-07-25
A 2,000-square-kilometer zone in the Yukon Flats of interior Alaska--one of the most flammable high-latitude regions of the world--has seen a dramatic increase in both the frequency and severity of fires in recent decades, according to research funded by the National Science Foundation (NSF).
Wildfire activity in this area is higher than at any other time in the past 10,000 years, the researchers report.
The research, funded by NSF's Division of Polar Programs, adds to the evidence that relatively frequent and powerful fires are converting the conifer-rich boreal ...